Advpharma, Inc.
Records under this name other than the patents Advpharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 7 of 7 · Back to Advpharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,955,800 | Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients Lapsed on the fee record Ended Jun 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2023 | From the USPTO record |
| US 7,741,464 | Compositions and methods of using CRMP-1 and its fragments for treating cancer Lapsed on the fee record Ended Jun 22, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2018 | From the USPTO record |
| US 7,655,779 | Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences Lapsed on the fee record Ended Feb 2, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 2, 2018 | From the USPTO record |
| US 6,635,649 | Piperazinedione compounds Formerly held Lapsed on the fee record Ended Oct 21, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 21, 2015 | From the USPTO record |
| US 7,223,792 | Cytotoxic annonaceous acetogenins from Annona muricata Lapsed on the fee record Ended May 29, 2011 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2011 | From the USPTO record |
| US 7,211,660 | Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences Lapsed on the fee record Ended May 1, 2011 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2011 | From the USPTO record |
| US 5,869,507 | Azatyrosine analogues Term ended Term ended no later than Feb 9, 2019 · Low confidence | Term ended | Term ended no later than Feb 9, 2019 | Low confidence |